Your browser doesn't support javascript.
loading
pH-Responsive doxorubicin delivery using shear-thinning biomaterials for localized melanoma treatment.
Lee, Junmin; Wang, Yonggang; Xue, Chengbin; Chen, Yi; Qu, Moyuan; Thakor, Jai; Zhou, Xingwu; Barros, Natan Roberto; Falcone, Natashya; Young, Patric; van den Dolder, Floor W; Lee, KangJu; Zhu, Yangzhi; Cho, Hyun-Jong; Sun, Wujin; Zhao, Bo; Ahadian, Samad; Jucaud, Vadim; Dokmeci, Mehmet R; Khademhosseini, Ali; Kim, Han-Jun.
Afiliação
  • Lee J; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90064, USA. khademh@terasaki.org.
  • Wang Y; Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), Pohang 790-784, Korea.
  • Xue C; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Chen Y; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Qu M; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Thakor J; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Zhou X; Guangdong Engineering & Technology Research Center for Quality and Efficacy Reevaluation of Post-Market Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, P. R. China.
  • Barros NR; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Falcone N; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Young P; Key Laboratory of Neuroregeneration, Ministry of Education and Jiangsu Province, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226001, P.R. China.
  • van den Dolder FW; Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
  • Lee K; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Zhu Y; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Cho HJ; Department of Research and Design, Beijing Biosis Healing Biological Technology Co., Ltd, Daxing District, Biomedical Base, Beijing 102600, P. R. China.
  • Sun W; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Zhao B; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Ahadian S; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Jucaud V; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Dokmeci MR; Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Khademhosseini A; Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Kim HJ; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90064, USA. khademh@terasaki.org.
Nanoscale ; 14(2): 350-360, 2022 Jan 06.
Article em En | MEDLINE | ID: mdl-34908077

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Melanoma Limite: Humans Idioma: En Revista: Nanoscale Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Melanoma Limite: Humans Idioma: En Revista: Nanoscale Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos